🇺🇸 FDA
Pipeline program

Carbetocin Short-infusion

2014-088

Approved small_molecule completed

Quick answer

Carbetocin Short-infusion for Complications; Cesarean Section is a Approved program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Complications; Cesarean Section
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials